iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
Lenacapavir (GS-6207): A First-in-Class Long Acting HIV Capsid Inhibitor
 
 
  HIV-DART Dec 10 2020

1215201

1215202

1215203

1215204

1215205

1215206

1215207

Gilead Sciences. Press Release. 18 Nov 2020. Available at: https://www.gilead.com/news-and-press/press-room/press-releases/2020/11/gilead-announcesinvestigational- longacting-hiv1-capsid-inhibitor-lenacapavir-achieves-primary-endpoint-in-phase-23-study-in-heavily-treatmentex

1215208

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org